Miah Roney

Kuantan, Malaysia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Unraveling the Systems Biology of Curcumin: A Mini-review of its Anti-diabetic Potential through Network Pharmacology.

Unraveling the Systems Biology of Curcumin: A Mini-review of its Anti-diabetic Potential through Network Pharmacology.

Journal: Cell biochemistry and biophysics
Published: September 02, 2025

Anti-malarial potential of novel aminoalkylated eugenol derivatives: synthesis, in-vitro, in-silico evaluation and mechanistic profiling.

Anti-malarial potential of novel aminoalkylated eugenol derivatives: synthesis, in-vitro, in-silico evaluation and mechanistic profiling.

Journal: Biochemical and biophysical research communications
Published: June 13, 2025

Repurposing of natural products for spinocerebellar ataxia type 3 using integrated network pharmacology and in silico approaches.

Repurposing of natural products for spinocerebellar ataxia type 3 using integrated network pharmacology and in silico approaches.

Journal: Scientific reports
Published: April 24, 2025

Exploring the anti-cancer potential of daidzin in breast cancer: Integrated bioinformatics and computational insights on oncogene inhibition.

Exploring the anti-cancer potential of daidzin in breast cancer: Integrated bioinformatics and computational insights on oncogene inhibition.

Journal: Computational biology and chemistry
Published: March 10, 2025

In-silico evaluation of diffractaic acid as novel anti-diabetic inhibitor against dipeptidyl peptidase IV enzyme.

In-silico evaluation of diffractaic acid as novel anti-diabetic inhibitor against dipeptidyl peptidase IV enzyme.

Journal: In silico pharmacology
Published: January 07, 2025

In silico identification of PPARγ agonists from diffractaic acid analogs in prostate cancer: a comprehensive computational approach.

In silico identification of PPARγ agonists from diffractaic acid analogs in prostate cancer: a comprehensive computational approach.

Journal: 3 Biotech
Published: December 29, 2024

Cu(II) complexes based on benzimidazole ligands: synthesis, characterization, DFT, molecular docking & bioactivity study.

Cu(II) complexes based on benzimidazole ligands: synthesis, characterization, DFT, molecular docking & bioactivity study.

Journal: Future medicinal chemistry
Published: November 12, 2024

Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches.

Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches.

Journal: Computational biology and chemistry
Published: November 07, 2024

Correction: In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment.

Correction: In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment.

Journal: Cell biochemistry and biophysics
Published: September 13, 2024

Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: in silico approaches.

Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: in silico approaches.

Journal: 3 Biotech
Published: August 08, 2024

Curcumin, a bioactive compound of Turmeric (Curcuma longa) and its derivatives as α-amylase and α-glucosidase inhibitors.

Curcumin, a bioactive compound of Turmeric (Curcuma longa) and its derivatives as α-amylase and α-glucosidase inhibitors.

Journal: Cell biochemistry and biophysics
Published: July 28, 2024

In silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase IV from isoxazole derivatives of usnic acid.

In silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase IV from isoxazole derivatives of usnic acid.

Journal: 3 Biotech
Published: July 15, 2024
Showing 1-12 of 36

Last Updated: 09/26/2026